Le Lézard
Classified in: Health
Subject: SPORTS

SweetWater Brewing Company Announces Partnership With Mercedes-Benz Stadium and Opens Two Branded Bars at Atlanta's Premier Sports and Entertainment Venue


ATLANTA, May 04, 2023 (GLOBE NEWSWIRE) --  SweetWater Brewing Company, LLC ("SweetWater Brewing" or "SweetWater"), a subsidiary of Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ: TLRY and TSX: TLRY), today announces a new partnership with Mercedes-Benz Stadium and the opening of two new branded bars at Atlanta's premier sports and entertainment venue, which is home to the NFL's Atlanta Falcons and Atlanta United of Major League Soccer. With this new partnership, sports fans and concert goers can now enjoy SweetWater beers throughout the stadium and at the new flagship SweetWater bars located on levels 100 and 300.

SweetWater's partnership with Mercedes-Benz Stadium, which has hosted more than 260 events and 230 million guests since opening in 2017, creates an authentically local experience at the world-class venue. SweetWater was founded in Atlanta in 1997, and the brewery's award-winning craft beer quickly developed a cult following and helped shape the vibrant craft-beer scene that exists in the city today. As part of the partnership, SweetWater is also the presenting sponsor and official beer partner of the ATLive concert series and the Summer Movie Experience at the Home Depot Backyard adjacent to Mercedes-Benz Stadium.

"This is another exciting new partnership as we continue our coast-to-coast expansion and serve our great beer to sports fans across the country," said Ty Gilmore, President, U.S. Beer, at Tilray Brands, SweetWater's parent company. "SweetWater has deep roots in Atlanta, and serving our beer at the city's premiere entertainment destination is one of the exciting new ways we're engaging with the community. We're thrilled for more of Atlanta's football and soccer fans, as well as the community at large, to sip their favorite SweetWater beers while taking in the fun at Mercedes-Benz Stadium."


"We are excited to partner with our hometown brewing company, Sweetwater, "says Vice President, Partnerships, AMB Sports and Entertainment, Dana Harple. "We are purposeful in bringing local Atlanta businesses inside Mercedes-Benz Stadium, not only to support locally owned businesses, but to expose guests from all over to the best of what Atlanta has to offer, Sweetwater is a premier example of Atlanta's finest, and we are proud to have them in the family."

SweetWater's best-selling beers are now flowing at the stadium, including their flagship 420 Extra Pale Ale, the widely popular India Pale Ale, and new releases Lager and Gone Trippin' West Coast-Style India Pale Ale.

About SweetWater Brewing:

One of Atlanta's original craft breweries, founded 26 years ago, SweetWater Brewing is now one of the largest craft brewers across the U.S. With two flagship breweries in Atlanta, Georgia, and Fort Collins, Colorado, SweetWater's award-winning craft beers and ready-to-drink cocktails are available coast to coast and in more states than ever before. Inspired by the outdoors, SweetWater is a passionate advocate for healthy waterways and conservation initiatives. Through its annual Save Our Water campaign, SweetWater continues to raise funds to support nonprofit organizations fighting for clean water and habitat conservation, including the Waterkeeper Alliance, Bonefish & Tarpon Trust, and Trout Unlimited.

For more information on SweetWater Brewing Company, please visit www.sweetwaterbrew.com and follow @SweetWaterBrew on all social platforms.

About Tilray Brands

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better ? one person at a time. Tilray Brands delivers on this mission by inspiring and empowering the worldwide community to live their very best life and by providing access to products that meet the needs of their mind, body, and soul while invoking wellbeing. Patients and consumers trust Tilray Brands to deliver a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray's unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information about Tilray Brands, visit www.tilray.com and follow @tilray on Instagram, Twitter, Facebook, and LinkedIn.
  
Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, "forward-looking statements") under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the "safe harbor" created by those sections and other applicable laws. Forward-looking statements can be identified by words such as "forecast," "future," "should," "could," "enable," "potential," "contemplate," "believe," "anticipate," "estimate," "plan," "expect," "intend," "may," "project," "will," "would," "ahead," and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

For further information:

SweetWater Brewing Company Media:

Chris Hong, christopher.hong@rygr.us, (970) 924 - 0704 ext. 2103,

Tilray Brands Media: Berrin Noorata, news@tilray.com

Tilray Brands Investors: Raphael Gross, (203) 682-8253, Raphael.Gross@icrinc.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/748b2fc8-100c-4b73-8065-dd8f08dc9ec3



These press releases may also interest you

at 08:35
Hologic Inc. and Bayer today announced an international partnership to deliver contrast-enhanced mammography (CEM) solutions to improve the detection of breast cancer for women in multiple countries across the European, Canadian and Asia Pacific...

at 08:35
Mirum Pharmaceuticals, Inc. , a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it is scheduled to participate...

at 08:35
Simulations Plus, Inc. , a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced it has been awarded a new funded grant from the U.S. Food and Drug...

at 08:35
Maze Therapeutics, a company translating genetic insights into new precision medicines, today announced that management will participate in a fireside chat at the 2023 Cantor Fitzgerald Global Healthcare Conference on Tuesday, September 26, 2023,...

at 08:30
via InvestorWire ? Genprex Inc. today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork ("IBN"), a multifaceted financial news and publishing company for private...

at 08:26
Dizal announced today that the China National Medical Products Administration (NMPA) has granted priority review status to golidocitinib, Dizal's investigational JAK1-only inhibitor, for the treatment of relapsed or refractory peripheral T-cell...



News published on and distributed by: